Christine Elizabeth Weiland, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8750 Fax: 515-727-8757 |
Jennifer Kristin Nelson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8750 Fax: 515-727-8757 |
Ms. Abbie Susan Black, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8750 Fax: 515-727-8757 |
Erin Reid Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8750 Fax: 515-727-8757 |
Jordan Pulliam Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8000 |
Emily Monahan, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8750 |
Bonnie Keller Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8750 Fax: 515-727-8757 |
Allison Lee Bennett, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-251-5558 |
Beth Hennes, MS,OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8750 Fax: 515-727-8757 |
Katherine Jansa, OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5406 Merle Hay Rd, Johnston, IA 50131 Phone: 515-727-8750 Fax: 515-727-8757 |
News Archive
Edwards Lifesciences Corporation, the leader in the sciences of heart valves and hemodynamic monitoring, and DexCom, Inc., a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems, today announced the receipt of CE Mark for an automatic glucose monitoring system.
Inhibitex, Inc., announced today that it has successfully completed a Phase1a, first-in-man, single ascending dose trial of INX-189, its nucleotide polymerase inhibitor in development for the treatment of chronic hepatitis C (HCV) infections. In this trial, 42 healthy volunteers received either a single oral dose of INX-189, ranging from 3 mg to 100 mg, or placebo. The Company plans to present detailed results from this trial during a future scientific meeting.
Researchers from Boston University School of Medicine's (BUSM) New England Centenarian Study have noted specific personality traits associated with healthy aging and longevity amongst the children of centenarians.
Barbara Kalinoski takes charge of things. She's been chair of the school board. President of the Laurentian Lakes Chapter of the North Country Trail Association. Director of the Northwest Regional Library. President of the Minnesota Library Association.
› Verified 6 days ago